Applied Therapeutics Inc. - APLT Net earnings per one share for the last twelve months

appliedtherapeutics.com (APLT) - corporate logo

Geopolitical instability and sanctions complicate raw material logistics and the execution of global tests for Applied Therapeutics (APLT). This daily price action for EPS (TTM) reflects profit dynamics, which currently stand at 93.00. The business relies on its authority in galactosemia therapy and the development of metabolic inhibitors, while effectively managing external contractors for molecule synthesis to offset any internal operational disruptions.

APLT: appliedtherapeutics.com Net earnings per share for the last 12 months 02/11/2024 - 02/16/2026

Applied Therapeutics, Inc. - analytical breakdowns and key metrics (APLT)

- stock quotes and analyst forecast:
Quote Chart Applied Therapeutics, Inc.|APLT - Analyst Consensus Forecast
- issuer market value details:
Market Value Applied Therapeutics|APLT - Enterprise Value
- company book value details:
Equity per Share Applied Therapeutics|APLT - Company Net Assets|Market Value to Book Value appliedtherapeutics.com|APLT - Aggregate Company Assets
- company total debt and liquidity indicators:
Aggregate Debt to Equity Applied Therapeutics|APLT - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Applied Therapeutics|APLT - Company Aggregate Debts|Debts to Book Capitalization Applied Therapeutics, Inc.|APLT - Company Long-Term Debt|Company Short-Term Loans and Borrowings Applied Therapeutics|Quick Liquidity Indicator appliedtherapeutics.com
- earnings and valuation multiples information:
APLT - Net Profit|Projected Future Earnings Applied Therapeutics|APLT - P/E Multiple|Forward P/E Multiple Applied Therapeutics Inc.|APLT - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Applied Therapeutics, Inc.|APLT - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Applied Therapeutics|APLT - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months appliedtherapeutics.com|APLT - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Applied Therapeutics
- sales volume and revenue information:
APLT - Revenue and Sales Volume|Company Expected Sales Volume Applied Therapeutics|APLT - P/S Multiple|Market Cap to Projected Revenue Applied Therapeutics
Fundamental company valuation:APLT - Applied Therapeutics Inc.
Brand item of appliedtherapeutics.com

Applied Therapeutics is transitioning from drug development to the commercial launch of products in the US and European markets. This chart of YoY TTM earnings per share tracks the rolling annual net income trend, allowing for the detection of a slowdown in expansion rates prior to the publication of financial reports. Investors should interpret extreme peaks in the curve as a signal that growth drivers have been exhausted and as a risk of asset overvaluation.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ARCT (Arcturus Therapeutics)|ETON: Net earnings per share (EPS TTM)|Kamada Ltd (KMDA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fulcrum Tx|ABEO: Earnings per share for the trailing year|Earnings per share for the last twelve months Mereo BioPharma Group (MREO)|Net earnings per share (EPS TTM) protalix.com (PLX)|Net earnings per share (EPS TTM) PLRX (Pliant Therapeutics Inc)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Net earnings per share (EPS TTM)|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)